New colonoscopy procedure aims to stop recurring gut infections

NCT ID NCT05831189

Summary

This study tested the safety and effectiveness of a treatment called RBX2660 (REBYOTA®) when given during a colonoscopy. It involved 41 adults suffering from recurrent C. difficile infections, a serious and debilitating gut condition. The goal was to see if this new delivery method could help control the infection and prevent it from coming back.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLOSTRIDIUM DIFFICILE INFECTION RECURRENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Ferring Investigational Site

    North Little Rock, Arkansas, 72117, United States

  • Ferring Investigational Site

    Camarillo, California, 93012, United States

  • Ferring Investigational Site

    Hamden, Connecticut, 06518, United States

  • Ferring Investigational Site

    Idaho Falls, Idaho, 83404, United States

  • Ferring Investigational Site

    Gurnee, Illinois, 60031, United States

  • Ferring Investigational Site

    Shreveport, Louisiana, 71105, United States

  • Ferring Investigational Site

    Plymouth, Minnesota, 55446, United States

  • Ferring Investigational Site

    Rochester, Minnesota, 55905, United States

  • Ferring Investigational Site

    Cleveland, Ohio, 44195, United States

  • Ferring Investigational Site

    Oklahoma City, Oklahoma, 73102, United States

  • Ferring Investigational Site

    Burke, Virginia, 22015, United States

  • Ferring Investigational Site

    Madison, Wisconsin, 53705, United States

Conditions

Explore the condition pages connected to this study.